Is therapeutic anticoagulation improving renal outcomes in COVID-19?
We present three patients with COVID-19 who developed acute renal failure during hospitalization and were seen to have an improvement in their kidney function after being started on therapeutic anticoagulation with heparin (Target PTT 58–93 seconds) for varying indications (atrial fibrillation, popl...
Main Authors: | Sohaib Roomi, Waqas Ullah, Soban Farooq, Rehan Saeed, Shujaul Haq, Ammar Ali Ashfaq |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2020-07-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2020.1785995 |
Similar Items
-
Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Sohil Elfar, et al.
Published: (2022-06-01) -
Anticoagulation in COVID-19: a single-center retrospective study
by: Sohaib Sanan Roomi, et al.
Published: (2021-01-01) -
Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation
by: Min Soo Cho, et al.
Published: (2023-04-01) -
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
by: Narender Goel, et al.
Published: (2020-09-01) -
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF
by: Sake J. van der Wall, et al.
Published: (2021-01-01)